ProPhase Labs, Inc.
PRPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | -$2 |
| % Growth | -29.2% | -12.9% | 157.6% | – |
| Cost of Goods Sold | $1 | $1 | $1 | -$3 |
| Gross Profit | -$0 | $1 | $1 | $1 |
| % Margin | -13.9% | 58.9% | 36.8% | -37.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $5 | $4 | $15 |
| SG&A Expenses | $4 | $5 | $4 | $15 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $5 | $5 | $4 | $15 |
| Operating Income | -$5 | -$4 | -$4 | -$15 |
| % Margin | -539.5% | -312.3% | -256% | 586.4% |
| Other Income/Exp. Net | -$2 | $0 | -$1 | -$1 |
| Pre-Tax Income | -$7 | -$4 | -$5 | -$16 |
| Tax Expense | -$0 | $1 | $0 | $15 |
| Net Income | -$7 | -$4 | $4 | -$34 |
| % Margin | -774.5% | -358.6% | 277.1% | 1,383.2% |
| EPS | -0.16 | -0.11 | 0.21 | -1.58 |
| % Growth | -45.5% | -152.4% | 113.3% | – |
| EPS Diluted | -0.16 | -0.11 | 0.21 | -1.58 |
| Weighted Avg Shares Out | 42 | 42 | 19 | 20 |
| Weighted Avg Shares Out Dil | 42 | 42 | 19 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $2 | $1 |
| EBITDA | -$4 | -$4 | -$3 | -$14 |
| % Margin | -497.4% | -286% | -177.2% | 576.4% |